Tiziana Life Sciences Ltd (TLSA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TLSA currently has 111M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 8.12% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2025 |
20-F filing | 111.5M shares outstanding |
110M | 0 |
| Mar 24, 2025 |
F-3 filing: The company may offer, issue and sell from time to time up to $250,000,000 of common shares, warrants to purchase common shares, and a combination of such securities. |
100M | 0 |
| May 10, 2024 |
20-F filing | 103.1M shares outstanding |
100M | 0 |
| Apr 26, 2023 |
20-F filing | 102.3M shares outstanding |
100M | 0 |
| May 23, 2022 |
20-F filing | 102.3M shares outstanding |
100M | 0 |
| May 17, 2021 |
20-F filing | 194.6M shares outstanding |
190M | 0 |
| Jan 26, 2021 |
F-3 filing: The filing is an F-3 form, indicating the company may offer and sell up to $250,000,000 of ordinary shares, in the form of American Depositary Shares, warrants to purchase ordinary shares, in the form of ADSs and a combination of such securities, separately or as units, in one or more offerings, and an ATM offering of Ordinary shares represented by ADSs having an aggregate offering price of up to US$100,000,000 through B. Riley Securities, Inc., as sales agent or principal. |
140M | 0 |
| Jun 17, 2020 |
20-F filing | 136.7M shares outstanding |
140M | 0 |
| Jan 22, 2020 |
F-3 filing: The filing registers an indeterminate number of ordinary shares, warrants, and units with an aggregate initial offering price not to exceed $75,000,000. |
N/A | 0 |